Skip to content

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here. Hide this message

Laboratory Medicine

Test Directory / Anti-Xa assay (Unfractionated Heparin (UFH), Fragmin/Dalteparin, Enoxaparin/Clexane, Innohep/Tinzaparin, Rivaroxaban, Apixaban or Orgaran/Danaparoid)

Anti-Xa assay (Unfractionated Heparin (UFH), Fragmin/Dalteparin, Enoxaparin/Clexane, Innohep/Tinzaparin, Rivaroxaban, Apixaban or Orgaran/Danaparoid)

Citrated Plasma

TestAnti-Xa assay (Unfractionated Heparin (UFH), Fragmin/Dalteparin, Enoxaparin/Clexane, Innohep/Tinzaparin, Rivaroxaban, Apixaban or Orgaran/Danaparoid)
Common Abbreviations
Profile Coagulation Screen added on the same sample
Clinical Indication APTT ratio (APR) are no longer in use to monitor UFH, and anti-Xa must be requested. Low molecular weight heparin (LMWH) and Rivaroxaban/Apixaban (DOAC) therapy is usually not monitored. LMWH measuring may be required when the patient is pregnant, obese, very young, elderly and those who have kidney disease or dysfunction. DOAC monitoring may be required if overdosed, compliance or prior surgery. Contact Consultant Haematologist for further advice.
Specimen TypeBlood
Sample TypeCitrated Plasma
Minimum Volume1 x 3mL (adult) 1 x 1mL (paed) (citrated plasma must be filled to bottle line)
Special PrecautionsMust state the type of anticoagulant on form and time sample taken post dose Fondaparinux and Edoxaban levels are sent to Sheffield
Stability4 hours
Turnaround Time1 hours (urgent) 4 hours (routine)
LaboratoryYork Hospital for all anti-Xa tests Scarborough for LMWH and UFH anti-Xa
Reference IntervalSee manufacturer's guidance for reference range
LimitationsHaemolysis, gross lipaemia, high haematocrit may interfere with measurement. Over or under filled samples cannot be used due to ratio between blood and citrate
Additional Information
A receptionist at an information stand reading some paperwork

Your Visit

Chinese Poland

View all languages >